Anti-TNF therapy linked to ‘modest’ extra SCC risk
A Swedish population-based study shows that treatment with tumour necrosis factor inhibitors significantly increases the risk of developing squamous cell carcinoma, but not basal cell carcinoma, in patients with rheumatoid arthritis.
Source: MedWire News - Category: Consumer Health News Tags: Oncology Source Type: news
More News: Arthritis | Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Health | Rheumatoid Arthritis | Rheumatology | Skin Cancer | Squamous Cell Carcinoma | Study